Your browser doesn't support javascript.
loading
Cardiovascular Outcomes in Aortopathy: GenTAC Registry of Genetically Triggered Aortic Aneurysms and Related Conditions.
Holmes, Kathryn W; Markwardt, Sheila; Eagle, Kim A; Devereux, Richard B; Weinsaft, Jonathan W; Asch, Federico M; LeMaire, Scott A; Maslen, Cheryl L; Song, Howard K; Milewicz, Dianna M; Prakash, Siddharth K; Guo, Dongchuan; Morris, Shaine A; Pyeritz, Reed E; Milewski, Rita C; Ravekes, William J; Dietz, H C; Shohet, Ralph V; Silberbach, Michael; Roman, Mary J.
Afiliação
  • Holmes KW; Department of Pediatrics, Oregon Health and Science University, Portland, Oregon, USA. Electronic address: holmesk@ohsu.edu.
  • Markwardt S; School of Public Health, Oregon Health and Science University, Portland, Oregon, USA.
  • Eagle KA; Division of Cardiology, University of Michigan Health System, Ann Arbor, Michigan, USA.
  • Devereux RB; Division of Cardiology, Weill Cornell Medicine, New York, New York, USA.
  • Weinsaft JW; Division of Cardiology, Weill Cornell Medicine, New York, New York, USA.
  • Asch FM; MedStar Cardiovascular Research Network, Washington, DC, USA.
  • LeMaire SA; Division of Cardiothoracic Surgery, Baylor College of Medicine, and Department of Cardiovascular Surgery, Texas Heart Institute, Houston, Texas, USA.
  • Maslen CL; Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon, USA.
  • Song HK; Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon, USA.
  • Milewicz DM; Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.
  • Prakash SK; Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.
  • Guo D; Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.
  • Morris SA; Division of Pediatric Cardiology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
  • Pyeritz RE; Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Milewski RC; Division of Cardiothoracic Surgery, Yale School of Medicine, New Haven, Connecticut, USA.
  • Ravekes WJ; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Dietz HC; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Shohet RV; Department of Medicine, John A. Burns School of Medicine, Honolulu, Hawaii, USA.
  • Silberbach M; Department of Pediatrics, Oregon Health and Science University, Portland, Oregon, USA.
  • Roman MJ; Division of Cardiology, Weill Cornell Medicine, New York, New York, USA.
J Am Coll Cardiol ; 79(21): 2069-2081, 2022 05 31.
Article em En | MEDLINE | ID: mdl-35618343
ABSTRACT

BACKGROUND:

The GenTAC (Genetically Triggered Thoracic Aortic Aneurysm and Cardiovascular Conditions) Registry enrolled patients with genetic aortopathies between 2007 and 2016.

OBJECTIVES:

The purpose of this study was to compare age distribution and probability of elective surgery for proximal aortic aneurysm, any dissection surgery, and cardiovascular mortality among aortopathy etiologies.

METHODS:

The GenTAC study had a retrospective/prospective design. Participants with bicuspid aortic valve (BAV) with aneurysm (n = 879), Marfan syndrome (MFS) (n = 861), nonsyndromic heritable thoracic aortic disease (nsHTAD) (n = 378), Turner syndrome (TS) (n = 298), vascular Ehlers-Danlos syndrome (vEDS) (n = 149), and Loeys-Dietz syndrome (LDS) (n = 121) were analyzed.

RESULTS:

The 25% probability of elective proximal aortic aneurysm surgery was 30 years for LDS (95% CI 18-37 years), followed by MFS (34 years; 95% CI 32-36 years), nsHTAD (52 years; 95% CI 48-56 years), and BAV (55 years; 95% CI 53-58 years). Any dissection surgery 25% probability was highest in LDS (38 years; 95% CI 33-53 years) followed by MFS (51 years; 95% CI 46-57 years) and nsHTAD (54 years; 95% CI 51-61 years). BAV experienced the largest relative frequency of elective surgery to any dissection surgery (254/33 = 7.7), compared with MFS (273/112 = 2.4), LDS (35/16 = 2.2), or nsHTAD (82/76 = 1.1). With MFS as the reference population, risk of any dissection surgery or cardiovascular mortality was lowest in BAV patients (HR 0.13; 95% CI 0.08-0.18; HR 0.13; 95% CI 0.06-0.27, respectively). The greatest risk of mortality was seen in patients with vEDS.

CONCLUSIONS:

Marfan and LDS cohorts demonstrate age and event profiles congruent with the current understanding of syndromic aortopathies. BAV events weigh toward elective replacement with relatively few dissection surgeries. Nonsyndromic HTAD patients experience near equal probability of dissection vs prophylactic surgery, possibly because of failure of early diagnosis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Ehlers-Danlos / Síndrome de Loeys-Dietz / Doença da Válvula Aórtica Bicúspide / Dissecção Aórtica / Síndrome de Marfan Tipo de estudo: Observational_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Ehlers-Danlos / Síndrome de Loeys-Dietz / Doença da Válvula Aórtica Bicúspide / Dissecção Aórtica / Síndrome de Marfan Tipo de estudo: Observational_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2022 Tipo de documento: Article